{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"2"}],"units":"Participants"}],"groups":[{"description":"Genistein daily throughout chemotherapy cycles 1 and 2, and placebo daily during chemotherapy cycles 3 and 4\n\nGenistein: Estrogen-like compound (isoflavone) derived from soybeans\n\nPlacebo: Pill that contains no medicine","id":"OG000","title":"Arm A: Genistein Followed by Placebo - GENISTEIN Cycles"},{"description":"Placebo daily throughout chemotherapy cycles 1 and 2, and genistein daily during chemotherapy cycles 3 and 4\n\nGenistein: Estrogen-like compound (isoflavone) derived from soybeans\n\nPlacebo: Pill that contains no medicine","id":"OG001","title":"Arm B: Placebo Followed by Genistein - GENISTEIN Cycles"},{"description":"Genistein daily throughout chemotherapy cycles 1 and 2, and placebo daily during chemotherapy cycles 3 and 4\n\nGenistein: Estrogen-like compound (isoflavone) derived from soybeans\n\nPlacebo: Pill that contains no medicine","id":"OG002","title":"Arm A: Genistein Followed by Placebo - PLACEBO Cycles"},{"description":"Genistein daily throughout chemotherapy cycles 1 and 2, and placebo daily during chemotherapy cycles 3 and 4\n\nGenistein: Estrogen-like compound (isoflavone) derived from soybeans\n\nPlacebo: Pill that contains no medicine","id":"OG003","title":"Arm B: Placebo Followed by Genistein - PLACEBO Cycles"}],"paramType":"NUMBER","reportingStatus":"POSTED","timeFrame":"From the first date study drug is taken until the last date that study drug is taken, about 8 - 12 weeks if there are no chemotherapy delays","title":"Percentage of Participants Requiring Reduced Treatment Doses Due to an Adverse Event","type":"SECONDARY","unitOfMeasure":"percentage of participants"}